This is not the official budget document.

Budget Summary FY2017

Search for line item


Outside Section 113
Data Current as of:  8/9/2016

Previous Outside Section Next Outside Section


Lyme Disease Mandated Benefit V

SECTION 113.   Chapter 176B of the General Laws is hereby amended by inserting after section 4II the following section:-

Section 4JJ. .(a) For the purposes of this section, "Long-term antibiotic therapy" and "Lyme disease" shall have the same mean as ascribed to them in section 12DD of chapter 112.

(b) A subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide coverage for long-term antibiotic therapy for a patient with Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient's symptoms, diagnostic test results, or response to treatment. An experimental drug shall be covered as a long-term antibiotic therapy if it is approved for any indication by the United States Food and Drug Administration; provided, however, that a drug, including an experimental drug, shall be covered for an off-label use in the treatment of Lyme disease if the drug has been approved by the United States Food and Drug Administration.